In Q1 2022, Boxer Capital held 46 positions worth $1.5B. They initiated 46 new positions. Their largest holding was SWTX ($117.2M).
Frequently asked questions
What stocks did Boxer Capital own in Q1 2022?
Boxer Capital held 46 biotech stocks in their 13F portfolio in Q1 2022. Their top positions include SWTX, ITOS, BEIGF, RVMD, RLAY. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Boxer Capital's portfolio worth in Q1 2022?
Boxer Capital's tracked biotech portfolio was worth $1.5B across 46 positions, with total assets under management of approximately $0.5B. Portfolio values are based on 13F filings with the SEC.
What did Boxer Capital buy in Q1 2022?
Boxer Capital initiated 46 new positions in Q1 2022, including SWTX, ITOS, BEIGF, RVMD, RLAY and 41 more. They also increased 0 existing positions.
What did Boxer Capital sell in Q1 2022?
Boxer Capital did not fully exit any positions in Q1 2022.
Is Boxer Capital a biotech fund?
San Diego-based biotech specialist investing across the full drug development lifecycle from preclinical through commercial. Takes concentrated positions with deep scientific due diligence, leveraging proximity to the Southern California biotech cluster.
Want AI analysis, insider signals, and catalyst overlays for Boxer Capital?
View latest Boxer Capital portfolio →